10/14/2025
features the latest and greatest research in infectious diseases, and the Healix Research Team is excited to be presenting 4 new collaborative studies with our esteemed physician partners. If you'll be attending the meeting, we invite you visit our studies and chat with the presenting authors.
Poster P374: Long-term Effectiveness of Long-Acting Cabotegravir and Rilpivirine in an Infectious Disease Office-Based HIV Program. Presented by Dr. Nikhil Bhayani on 10/20/25 from 12:15-1:30PM ET.
Poster P-1020: Real-World Effectiveness and Health-Related Quality of Life Improvements Using Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection. Presented by Dr. Lucinda Van Anglen on 10/21/25 from 12:15-1:30PM ET. This study will also be included in a Rapid Fire Session entitled, Breaking Bad: Cooking Up Solutions For IP and AS, to be held on 10/21/25 from 12:15-12:45PM ET in Poster Hall B4-5 - Arena 3.
Poster P-1958: Efficacy and Safety of Rezafungin, A Long-Acting Echinocandin. Presented by Dr. Rick Hengel and Dr. Lucinda Van Anglen on 10/22/25 from 12:15-1:30PM ET in Poster Hall B4-5.
Oral Presentation: Early Experience with Use of Pemivibart for the Pre-exposure Prophylaxis of Coronavirus Disease 2019. Presented by Dr. Brian Metzger on 10/22/25 from 3:15-4:30PM ET.
If you're interested in learning more about our research studies or partnering with Healix, contact infusiontherapy@healix.net. We hope to visit with you at IDWeek!